QELBREE
These highlights do not include all the information needed to use QELBREE safely and effectively. See full prescribing information for QELBREE . QELBREE (viloxazine extended-release capsules), for oral use Initial U.S. Approval: 2021
aedf408d-0f84-418d-9416-7c39ddb0d29a
HUMAN PRESCRIPTION DRUG LABEL
Dec 20, 2023
Supernus Pharmaceuticals, Inc
DUNS: 363066452
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
viloxazine hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (24)
viloxazine hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (24)
viloxazine hydrochloride
Product Details
FDA regulatory identification and product classification information